Finerenone in Patients with Type 2 Diabetes and CKD by SGLT2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists Receptor Agonist Use: A FIDELITY Analysis

Authors: Ajay K. Singh, Stefan D. Anker, Bertram Pitt, Peter Rossing, Luis M. Ruilope, Christiane Ahlers, Youssef MK Farag, Marc Lambelet, Meike Daniela Brinker, Katja Rohwedder, Gerasimos Filippatos, George L. Bakris

Published: 2024-10-28

DOI: 10.1681/asn.2024z6zpnkzd

Keywords: No keywords found.

Abstract:
No abstract found.

Source: